1-800-TEMPLE-MED

Newsroom
Page size:
select
 616 items in 62 pages
 
Page size:
select
 616 items in 62 pages

Temple University Hospital Earns ANCC Magnet Recognition


(Philadelphia, PA) – Temple University Hospital has achieved Magnet designation from the American Nurses Credentialing Center (ANCC), considered the highest honor and form of recognition for nursing excellence. Only about 8 percent of U.S. health care organizations have achieved the honor of Magnet status.
read more »

Temple Researchers Identify Long-Sought Activator of Sigma Receptors in Human Cells, Marking Important Advance in Cell Biology


(Philadelphia, PA) – Cells communicate through complex mechanisms that typically involve receptors and ligands that bind to them. Endogenous ligands, produced by the body, have been identified for the vast majority of cellular receptors, helping explain receptor existence and function. But in the case of sigma-1 receptors, which interact with a diverse array of psychoactive drugs, an endogenous ligand has remained elusive. Now, researchers at the Lewis Katz School of Medicine at Temple University, in collaboration with scientists at the University of Cambridge, show that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology.
read more »

Thomas Jefferson University and Temple University
Enter Exclusive Negotiations


(Philadelphia, PA) - Two of Philadelphia’s leading academic and healthcare organizations have signed an agreement that creates an exclusive 90-day window within which to consider and negotiate the acquisition and conduct due diligence by Jefferson of the Fox Chase Cancer Center.
> read more »

Lewis Katz School of Medicine at Temple University Receives $100,000 Donation from Stop Alzheimer’s Now to Conduct Groundbreaking Study


(Philadelphia, PA) – Beneath the amyloid plaques and neurofibrillary tangles that are the hallmark pathological features of Alzheimer's disease, is another, lesser-known anomaly: the almost complete absence of adult neurogenesis, the process by which new neurons form in the developed brain. Thought to serve a critical role in maintaining memory and learning ability, little is actually known about the significance of reduced adult neurogenesis in Alzheimer's disease. Now, scientists at the Lewis Katz School of Medicine at Temple University have a chance to find out, thanks to a $100,000 gift from Stop Alzheimer's Now, a non-profit organization dedicated to eradicating Alzheimer's disease.
read more »

Temple Awarded 5-year, $3.47 Million NIH Grant to Investigate Evidence-Based Treatment Approach to Prevent Excessive Weight Gain in Pregnancy


(Philadelphia, PA) – The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has awarded a Temple-led research team a 5-year, $3.47 million grant. The team will partner with the Women, Infants and Children (WIC) Food and Nutrition program of Philadelphia to investigate an evidence-based treatment approach for the prevention of excessive weight gain in pregnancy among the medically vulnerable women WIC serves.
read more »

Temple Plays Leading Role in FDA Approval of a New Minimally Invasive Endobronchial Treatment for Severe Emphysema


(Philadelphia, PA) – Back in September, Dr. Gerard Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, announced 12-month results of the EMPROVE multicenter, randomized and controlled study for the Spiration® Valve System (SVS), a minimally invasive treatment for severe emphysema, at the European Respiratory Society International Congress (ERS) in Paris, France.

Now, thanks to those positive results, which indicated statistical and clinically meaningful improvements in lung function, target lobe volume reduction, shortness of breath and quality-of-life parameters, the U.S. Food and Drug Administration (FDA) has granted the Spiration® Valve System approval under its breakthrough medical devices designation along with priority review status.
read more »

Temple-Led Research Team Traces Pathway
to Cardioprotection in Post-Ischemic Heart Failure


(Philadelphia, PA) – During an ischemic attack, the heart is temporarily robbed of its blood supply. The aftermath is devastating: reduced heart contractility, heart cell death, and heart failure. Contributing to these detrimental changes is a signaling molecule, G protein-coupled receptor kinase 2 (GRK2), which following ischemia accumulates in mitochondria, the energy-producing powerhouses of cells. Now, a Temple-led research team shows for the first time that blocking GRK2 localization to mitochondria protects heart cells from ischemic injury and death, casting new light on GRK2 as a potential therapeutic target in post-injury heart failure.
read more »

Temple Scientists Identify Novel Target for Neuron Regeneration and Functional Recovery in Spinal Cord Injury


(Philadelphia, PA) – Restoring the ability to walk following spinal cord injury requires neurons in the brain to reestablish communication pathways with neurons in the spinal cord. Mature neurons, however, are unable to regenerate their axons to facilitate this process. Now, in new research, scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) show that this limitation may be overcome by targeting liver kinase B1 (LKB1) protein. In mice with spinal cord injury, targeted LKB1 upregulation stimulated long-distance neuron regeneration, leading to gains in functional recovery.
read more »

Dr. Lisa Rae Appointed Director of the Temple Burn Center


(Philadelphia, PA) – Lisa Rae, MD, FACS, has been appointed Director of the Temple Burn Center and Associate Professor of Surgery at the Lewis Katz School of Medicine at Temple University. Prior to joining Temple, Dr. Rae was an Assistant Professor of Surgery in the Division of Trauma, Surgical Critical Care, and Burn Surgery at Vanderbilt University Medical Center. She was also Director of the hospital’s Burn Surgical Fellowship program.
read more »

Dr. William Auger Joins Temple as Chronic
Thromboembolic Pulmonary Hypertension Specialist


(Philadelphia, PA) – William R. Auger, MD, has joined Temple University Hospital as a pulmonologist in the Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program in the Temple Heart and Vascular Institute, and Clinical Professor of Medicine at the Lewis Katz School of Medicine at Temple University.
read more »